These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 7506337)

  • 21. Treatment of ascites in cirrhosis. Diuretics, peritoneovenous shunt, and large-volume paracentesis.
    Arroyo V; Ginès P; Planas R
    Gastroenterol Clin North Am; 1992 Mar; 21(1):237-56. PubMed ID: 1568775
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of diuretics in the treatment of cirrhotic ascites.
    Boyer TD; Warnock DG
    Gastroenterology; 1983 May; 84(5 Pt 1):1051-5. PubMed ID: 6832557
    [No Abstract]   [Full Text] [Related]  

  • 23. Torasemide in the treatment of patients with cirrhosis and ascites.
    Gentilini P; Laffi G; La Villa G; Carloni V; Foschi M; Romanelli RG; Marra F
    Cardiovasc Drugs Ther; 1993 Jan; 7 Suppl 1():81-5. PubMed ID: 8435382
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An optimal diuretic regimen for cirrhotic ascites. A controlled trial evaluating safety and efficacy of spironolactone and furosemide.
    Fuller RK; Khambatta PB; Gobezie GC
    JAMA; 1977 Mar; 237(10):972-5. PubMed ID: 319263
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of clonidine on diuretic response in ascitic patients with cirrhosis and activation of sympathetic nervous system.
    Lenaerts A; Codden T; Meunier JC; Henry JP; Ligny G
    Hepatology; 2006 Oct; 44(4):844-9. PubMed ID: 17006921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bumetanide, spironolactone and a combination of the two, in the treatment of ascites due to liver disease. A prospective, controlled, randomized trial.
    Sarin SK; Sachdev G; Mishra SP; Sundaram KR; Shrivastwa A; Talukdar V; Broor SL
    Digestion; 1988; 41(2):101-7. PubMed ID: 3065101
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spironolactone alone or in combination with furosemide in the treatment of moderate ascites in nonazotemic cirrhosis. A randomized comparative study of efficacy and safety.
    Santos J; Planas R; Pardo A; Durández R; Cabré E; Morillas RM; Granada ML; Jiménez JA; Quintero E; Gassull MA
    J Hepatol; 2003 Aug; 39(2):187-92. PubMed ID: 12873814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of diuretics on chronic liver disease.
    Steigmann F; Mejicano R
    Am J Gastroenterol; 1969 Jul; 52(1):37-44. PubMed ID: 5796683
    [No Abstract]   [Full Text] [Related]  

  • 29. Pathophysiology of ascites and dilutional hyponatremia: contemporary use of aquaretic agents.
    Leiva JG; Salgado JM; Estradas J; Torre A; Uribe M
    Ann Hepatol; 2007; 6(4):214-21. PubMed ID: 18007550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictive factors influencing the therapeutic response to diuretic treatment of ascites in nonazotemic cirrhotic patients.
    Ljubicić N; Kujundzić M; Banić M; Vrkljan M
    Scand J Gastroenterol; 1998 Apr; 33(4):441-7. PubMed ID: 9605268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparative study of diuretic drugs used in cirrhotic and ascitic patients].
    Lennhoff M; Duhalt R; Peña JC
    Rev Invest Clin; 1968; 20(2):165-80. PubMed ID: 5721631
    [No Abstract]   [Full Text] [Related]  

  • 32. The effects of treatment with octreotide, diuretics, or both on portal hemodynamics in nonazotemic cirrhotic patients with ascites.
    Kalambokis G; Economou M; Kosta P; Papadimitriou K; Tsianos EV
    J Clin Gastroenterol; 2006 Apr; 40(4):342-6. PubMed ID: 16633107
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of captopril therapy on sodium and water excretion in patients with liver cirrhosis and ascites].
    Brunkhorst R; Wrenger E; Kühn K; Schmidt FW; Koch K
    Klin Wochenschr; 1989 Aug; 67(15):774-83. PubMed ID: 2671477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bumetanide in refractory ascites of cirrhosis of the liver: a comparison with furosemide.
    Iber FL; Baum RA
    J Clin Pharmacol; 1981; 21(11):697-700. PubMed ID: 7338581
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Biological factors influencing response to diuretics in patients with cirrhosis and ascites].
    Lenaerts A; Codden T; Henry JP; Van Cauter J; Meunier JC; Ligny G
    Gastroenterol Clin Biol; 2001 Mar; 25(3):268-72. PubMed ID: 11395674
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The clinical pharmacology of loop diuretics in the pediatric patient.
    Eades SK; Christensen ML
    Pediatr Nephrol; 1998 Sep; 12(7):603-16. PubMed ID: 9761364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Diuretics].
    Schwartz J; Bloch R; Imbs JL; Spach MO
    Pathol Biol (Paris); 1986 Sep; 34(7):861-85. PubMed ID: 3537932
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Reasons for diuretic therapy of cirrhotic ascites].
    Parlapiano C; Paoletti V
    Minerva Med; 1985 Nov; 76(43):2043-6. PubMed ID: 3934593
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renal effects of treatment with diuretics, octreotide or both, in non-azotemic cirrhotic patients with ascites.
    Kalambokis G; Economou M; Fotopoulos A; Bokharhii JA; Katsaraki A; Tsianos EV
    Nephrol Dial Transplant; 2005 Aug; 20(8):1623-9. PubMed ID: 15886218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of albumin/furosemide mixtures on responses to furosemide in hypoalbuminemic patients.
    Chalasani N; Gorski JC; Horlander JC; Craven R; Hoen H; Maya J; Brater DC
    J Am Soc Nephrol; 2001 May; 12(5):1010-1016. PubMed ID: 11316860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.